Question of Week | What do new ADA/EASD Standards Recommend?
The new ADA /EASD Management of Hyperglycemia in Type 2 Consensus Statement 2022 was just released.
Which of the following is an accurate recommendation according to these updated guidelines?
- Initiate treatment with metformin for most individuals, including those with cardiovascular disease.
- If A1C not at target with 2 or more oral agents, add on basal insulin therapy.
- Avoid the use of SGLT-2 Inhibitors in those with an eGFR of less than 25.
- Prioritize the use of organ protective medications in those with cardiorenal disease.
Click Here to Test your Knowledge
Want to learn more about this question? Join us for our
Meds for Type 2 Update; New ADA/EASD Consensus Statement
Level 2 | 1.25 CEs
Airs live on Wednesday, December 1st at 11:30 am PST
Plan on joining this exciting webinar that walks participants through the newly released, “Management of Hyperglycemia in Type 2 Consensus Report by the ADA and EASD”. These updated guidelines will be incorporated into the 2023 ADA Standards of Care, but you can get a early sneak peak by joining Coach Beverly on December 1st, 2022. She will highlight the revised guidelines with a focus on new elements and exciting changes on how we approach medication management for type 2 diabetes. Together, we will explore clinical factors to consider when determining the best strategy to improve glucose management in people with type 2 diabetes and other co-conditions. There will be a special focus on cardiovascular risk reduction and renal protection and addressing clinical inertia.
Objectives:
- Describe the role of Diabetes Care and Education Specialists in advocating for optimal therapeutic approaches.
- Discuss the application of the new ADA/EASD Guidelines to improve glucose and reduce CV and renal risk.
- List strategies to initiate and adjust oral and injectable therapy using a person-centered approach
Intended Audience: A great course for health care professionals seeking evidence-based information that improves the quality of life and outcomes.
Don’t worry if you can’t make it live. Your registration guarantees access to the recorded version in the Online University.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Question of Week | How does metformin impact cancer risk?
JR is taking Metformin 1000mg BID but is worried that it may increase their risk of cancer and is thinking about stopping the metformin.
Which of the following is an accurate statement regarding metformin, cancer and safety?
- There is research suggesting that metformin may be associated with a decreased risk of certain cancers.
- People with diabetes have a slightly lower risk of liver and uterine cancers
- Some brands of metformin were recalled because of an NDMA impurity, so it is best to avoid metformin for now.
- Metformin does not increase the risk of cancer, but it can negatively impact renal function.
Click Here to Test your Knowledge
Want to learn more about this question? Join us for our
Level 4 | Cancer and Diabetes | 1.25 CEs
Airs live on Wednesday, October 26th at 11:30 am PST
Diabetes Education Services Online University Courses are an excellent way to study for your exam anytime and anywhere that is convenient for you. You will have immediate access to your courses for 1 year after your purchase date. Each individual online course includes a: video presentation, podcast, practice test and additional resources.
Patients with cancer often experience hyperglycemia secondary to treatment, which can increase risk of infection and compromise their nutritional status. In addition, recent research has identified the link between diabetes and cancer. Join us to learn more about this unexpected link and treatment strategies for steroid induced hyperglycemia using a case study approach.
Objectives:
- Discuss the relationship between cancer, hyperglycemia and insulin resistance.
- State 3 benefits of normalizing glucose levels during chemotherapy.
- Using a case study approach, discuss strategies to improve glucose levels and quality of life.
Intended Audience: These courses are knowledge-based activities designed for individual or groups of diabetes educators, including RNs, RDs, Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants and other health care providers interested in enhancing their knowledge of diabetes management for people with cancer.
Don’t worry if you can’t make it live. Your registration guarantees access to the recorded version in the Online University.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Question of Week | Basal, Bolus and Blood Transfusions
JZ is excited about their A1c of 5.4%. They take bolus insulin 4 times a day, plus basal insulin at night. To treat their leukemia, JZ receives blood transfusions weekly.
What is your biggest concern?
- Is JZ experiencing lipohypertrophy?
- Why is JZ on multiple daily doses?
- Is JZ adjusting insulin for exercise?
- What is JZ’s fructosamine level?
Click Here to Test your Knowledge
Want to learn more about this question? Join us for our
Level 4 | Cancer and Diabetes | 1.25 CEs
Airs live on Wednesday, October 26th at 11:30 am PST
Diabetes Education Services Online University Courses are an excellent way to study for your exam anytime and anywhere that is convenient for you. You will have immediate access to your courses for 1 year after your purchase date. Each individual online course includes a: video presentation, podcast, practice test and additional resources.
Patients with cancer often experience hyperglycemia secondary to treatment, which can increase risk of infection and compromise their nutritional status. In addition, recent research has identified the link between diabetes and cancer. Join us to learn more about this unexpected link and treatment strategies for steroid induced hyperglycemia using a case study approach.
Objectives:
- Discuss the relationship between cancer, hyperglycemia and insulin resistance.
- State 3 benefits of normalizing glucose levels during chemotherapy.
- Using a case study approach, discuss strategies to improve glucose levels and quality of life.
Intended Audience: These courses are knowledge-based activities designed for individual or groups of diabetes educators, including RNs, RDs, Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants and other health care providers interested in enhancing their knowledge of diabetes management for people with cancer.
Don’t worry if you can’t make it live. Your registration guarantees access to the recorded version in the Online University.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Question of Week | To Prevent Hypo’s, JR Stopped Taking Bolus Insulin
Click Here to Test your Knowledge
JR is 26 years old with type 1 diabetes for over a decade. JR keeps missing appointments and when you finally get a hold of them on the phone, they start crying and say “I am afraid my blood sugars will go too low, so I stopped using my bolus insulin”. They explain that they were too embarrassed to come in and have their data downloaded. Based on this information, what would be the most helpful approach?
- Provide reassurance and recognize that JR is dealing with childhood trauma.
- Encourage JR to start using half their usual dose of bolus insulin to get started.
- Recognize JR’s effort to prevent low blood sugars and explore their feelings.
- Remind JR that all of the downloaded data and reports are confidential.
Click Here to Test your Knowledge
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Question of the Week | Best approach for distress & DKA?
RJ is in the hospital for the 3rd time this year in DKA. You ask RJ to complete the diabetes distress survey tool and immediately recognize that RJ is experiencing high levels of diabetes distress.
When working with RJ to assess what is happening, which of the following approaches could be used as a conversational tool?
- Use closed-ended questions to create a safe space for the interaction.
- Keep your clinical reports and records handy to use for reference.
- Accept RJ’s current self-management regimen without judgement.
- Avoid use of too many feeling words because it might embarrass RJ.
Click Here to Test your Knowledge
Want to learn more about this question? Join our NEW
ReVive 5 Diabetes Training Program | 14 CEs
Whether you are a novice or an expert in providing diabetes care, we invite you to attend this exciting training program that provides the essential steps to address diabetes distress combined with an innovative approach to glucose management that will revolutionize your practice.
“ReVive 5” breathes new life into our relationship with diabetes, bringing a fresh perspective to both the person with with diabetes and the provider.
By addressing old habits that no longer serve us, we have the opportunity to create a new life tool kit toolkit in partnership with the person living with diabetes.
The ReVive 5 program is built on sound research and will revolutionize your approach to diabetes self-management education.
Join our Team of Experts | Starts Nov 1st, 14 CEs
Team of Experts:
ReVive 5 is taught by a team of 3 Interdisciplinary Experts:
- Lawrence Fisher, Ph.D., ABPP, Professor Emeritus, UCSF
- Susan Guzman, PhD
- Beverly Thomassian, RN, MPH, CDCES, BC-ADM
Training Program Includes:
- 14.0 CEs – Includes the 4 Session ReVive Training Program, Certificate and 5 FREE bonus courses to supplement content
(Four 1.5 hour training sessions (6.0 CEs) plus Five bonus courses worth 9.0 CEs) - Quarterly 1 hour follow-up sessions with an expert -dates to be announced
- A comprehensive set of assessment tools, educational materials, log sheets and resources.
Don’t worry if you can’t make it live. Your registration guarantees access to the recorded version in the Online University.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Question of Week | JT is Carb limiting to 30gms a day. Best Response?
JT has type 1 diabetes and tells you they are avoiding carbs and trying to eat less than 30gms of carbs daily. JT is 76 years old, with an A1C of 6.6% and a BMI of 22.
What is the best response?
- Suggest JT try to eat a minimum of 30- 45 gms of carb per meal.
- Gently suggest to JT that they might have disordered eating.
- Explore JT’s reasons for avoiding carbs.
- Provide a review of carb portions and refer JT to an RD/RDN.
Click Here to Test your Knowledge
Want to learn more about this question? Join our NEW
ReVive 5 Diabetes Training Program
Whether you are a novice or an expert in providing diabetes care, we invite you to attend this exciting training program that provides the essential steps to address diabetes distress combined with an innovative approach to glucose management that will revolutionize your practice.
“ReVive 5” breathes new life into our relationship with diabetes, bringing a fresh perspective to both the person with diabetes and the provider.
By releasing old habits that no longer serve us, we have the opportunity to create a new life tool kit toolkit in partnership with the person living with diabetes.
The ReVive 5 program is built on international research study results and will revolutionize your approach to diabetes self-management education.
Join our Team of Experts
Team of Experts:
ReVive 5 is taught by a team of 3 Interdisciplinary Experts:
- Lawrence Fisher, Ph.D., ABPP, Professor Emeritus, UCSF
- Susan Guzman, PhD
- Beverly Thomassian, RN, MPH, CDCES, BC-ADM
Accredited Training Program:
- 15.0 CEs – Includes the 7-hour ReVive 5 Training Program, Certificate, and 5 FREE bonus courses to supplement content.
- Free Quarterly ReVive 5 Connect – connect with the instructors to help with problem-solving for an hour four times a year (see dates below).
- A comprehensive set of assessment tools, educational materials, log sheets, and resources.
Dates and Times for ReVive Virtual Training
- For your convenience, we have combined the 4 sessions into 2 half days. Same great content.
- July 19 and 26th from 9 am to 12:30 pm PST. Space is limited, so save your space today!
Don’t worry if you can’t make it live. Your registration guarantees access to the recorded version in the Online University.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Question of Week | Best action before starting tirzepatide (Mounjaro)?
AR is 36 years old with type 2 diabetes and a BMI of over 40. Current A1C 7.9%, UACR less than 30, and GFR more than 60. Current diabetes medications include metformin, sitagliptin, and empagliflozin at maximum doses. AR is prescribed the new dual incretin tirzepatide (Mounjaro) to help improve glucose levels and support weight loss.
Before starting tirzepatide (Mounjaro), what action do you recommend to the provider?
- Repeat the UACR and GFR to verify kidney function.
- Stop the sitagliptin.
- Decrease metformin dose to prevent hypoglycemia.
- Evaluate thyroid function.
Click Here to Test your Knowledge
New Injectable – “TwinCretin” on Printed PocketCards
We have just added this novel, first in class, dual incretin hormone therapy, Tirzepatide (Mounjaro), to our printed version of our Diabetes Medication PocketCard.
This new twin therapy includes not only a GLP-1 Receptor Agonist, but also a Glucose-dependent insulinotropic polypeptide (GIP), which magnifies the therapeutic effectiveness. The SURPASS studies indicate that study participants experienced an A1C drop of up to 2.5% and weight loss of up to 10kg or more.
Want to learn more about Diabetes Medications?
Virtual DiabetesEd Training Conference | 30+ CEs
Airs October 12-14th, 2022
Join us LIVE for this Virtual Training Conference and enjoy a sense of community!
Whether you are new to diabetes or a seasoned expert, you’ll benefit from this virtual conference with the latest research plus critical content that you can immediately apply to your clinical practice.
Download Course Flyer | Download Schedule
If you are seeking a state-of-the-art review of current diabetes care, this course is for you. Our team has been fine-tuning this course for over fifteen years, and we know what you need. This program can also be a great addition to your CDCES or BC-ADM exam study plan.
Team of expert faculty includes:
- Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES – Educator of the Year, 2020
- Coach Beverly Thomassian, RN, MPH, CDCES, BC-ADM
- Ashley LaBrier, MS, RD, CDCES, Diabetes Program Coordinator
Two Registration Options
Don’t worry if you can’t make it live. Your registration guarantees access to the recorded version in the Online University.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
Question of Week | What explains JR’s sudden DKA?
JR, a 67-year-old with type 2 diabetes for seven years and an A1C of 9.7% was started on empagliflozin 10mg two weeks ago. Other labs include a GFR of 49 and a UACR of 34 mg/g. Other diabetes medications include glucotrol 10mg twice daily and sitagliptin 100mg daily. JR sometimes has a few shot’s of whiskey before bed, especially if they had a stressful day. JR’s partner calls you in a panic and says JR is admitted to the hospital in DKA.
What is the most likely explanation?
- Excess alcohol intake leading to starvation ketosis
- Potential side effect of SGLT-2 Inhibitors
- Low GFR and elevated UACR increase hyperglycemic risk
- JR is misdiagnosed and likely has type 1 diabetes
Click Here to Test your Knowledge
Want to learn more about Diabetes Medications and Side Effects? Dr. Diana Isaacs will be sorting fact from fiction in our
Virtual DiabetesEd Training Conference | 30+ CEs
Airs October 12-14th, 2022
Join us LIVE for this Virtual Training Conference and enjoy a sense of community!
Whether you are new to diabetes or a seasoned expert, you’ll benefit from this virtual conference with the latest research plus critical content that you can immediately apply to your clinical practice.
Download Course Flyer | Download Schedule
If you are seeking a state-of-the-art review of current diabetes care, this course is for you. Our team has been fine-tuning this course for over fifteen years, and we know what you need. This program can also be a great addition to your CDCES or BC-ADM exam study plan.
Team of expert faculty includes:
- Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES – Educator of the Year, 2020
- Coach Beverly Thomassian, RN, MPH, CDCES, BC-ADM
- Ashley LaBrier, MS, RD, CDCES, Diabetes Program Coordinator
Two Registration Options
Don’t worry if you can’t make it live. Your registration guarantees access to the recorded version in the Online University.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE! Sign up below!
The use of DES products does not guarantee the successful passage of the CDCES exam. CBDCE does not endorse any preparatory or review materials for the CDCES exam, except for those published by CBDCE.
![](/wp-content/uploads/2023/01/insta-png-v5.png")
